Results 191 to 200 of about 32,524 (285)
Glycemic variability and entero-pancreatic hormones signatures after different bariatric surgery procedures: a cross-sectional study. [PDF]
Lobato CB +7 more
europepmc +1 more source
The authors propose a novel use for the conventional hypoglycemic drug, dipeptidyl peptidase IV (DPP4+) inhibitor sitagliptin. Sitagliptin prevents scar formation during wound healing through fibroblast‐to‐adipocyte conversion at least by preventing DPP4‐mediated truncation of IGF‐1.
Ju‐Lei Zhang +14 more
wiley +1 more source
Habit-learning and decision-making circuits are susceptible to glycemic variability in type 2 diabetes: a longitudinal study. [PDF]
Moreno C +5 more
europepmc +1 more source
ABSTRACT Objective To estimate the impact of state‐level insulin out‐of‐pocket caps on changes in out‐of‐pocket and total costs of insulin and healthcare for insulin users with employer‐sponsored insurance. Study Setting and Design We evaluated changes in costs using a quasi‐experimental (triple difference‐in‐differences; “DDD”) design to analyze multi‐
Khrysta A. Baig +4 more
wiley +1 more source
Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study. [PDF]
Wang Y +6 more
europepmc +1 more source
In a 12‐month weight‐loss trial, DunedinPACE was associated with cardiometabolic biomarkers at baseline, but not over time. No evidence supported epigenetic clocks as mediators of intervention effects, raising caution about their causal mechanisms as short‐term intervention targets for healthy aging. ABSTRACT Epigenetic clocks have emerged as promising
Minghao Kou +5 more
wiley +1 more source
Association between the postoperative glycemic variability and mortality after craniotomy: a retrospective cohort study and development of a mortality prediction model. [PDF]
Ge Y, Wang G, Huang Y, Zhang Y.
europepmc +1 more source
Canagliflozin enhances hippocampal function, reduces Aβ pathology, and improves cognitive function in male mice, while females show limited benefits, revealing sex‐specific neuroprotective responses across aging and Alzheimer's models. ABSTRACT Aging is the strongest risk factor for cognitive decline and Alzheimer's disease (AD), yet the mechanisms ...
Hashan Jayarathne +11 more
wiley +1 more source

